RachelleLancianoMD

Radiation Oncology • Broomall, PA

Gynecologic Cancer, Thoracic Cancer, Urologic Cancer

Physician

Join to view full profile

Dr. Lanciano is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lanciano's full profile

Already have an account?

Office
Crozer-Keystone Regional Cancer Center at Broomall
30 Lawrence Rd, Ste 200
Broomall, PA 19008
Phone+1 484-446-3636

Fax+1 484-446-3637

Education & Training

University of Pennsylvania Health SystemResidency, Radiation Oncology, 1985 - 1988
MCP-Hahnemann College of MedicineClass of 1984

Certifications & Licensure

PA State Medical License 1985 - 2024
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2013

Clinical Trials

Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix Start of enrollment: 1997 Oct 01
Completed
Phase 3
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Start of enrollment: 2008 Feb 25
Active, not recruiting
Phase 2
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide Start of enrollment: 2008 Mar 01
Active, not recruiting
Phase 3
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2009 Sep 01
Active, not recruiting
Phase 3
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery Start of enrollment: 2010 Apr 05
Active, not recruiting
Phase 3
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer Start of enrollment: 2012 May 01
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

639 citations
Reducing Uncertainties About the Effects of Chemoradiotherapy for Cervical Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 18 Randomized ...
Claire L Vale, Jayne F. Tierney, Lesley A. Stewart, Mark F. Brady, Ketayun A. Dinshaw
Journal of Clinical Oncology. 2008-12-10
10 citations
Repeat Thoracic Stereotactic Body Radiation Therapy (SBRT) for Nonsmall Cell Lung Cancer: Long-Term Outcomes, Toxicity, and Dosimetric Considerations.
A. Ricco, Sara Barlow, Jing Feng, Janson Jacob, Alicia Lozano
Advances in Radiation Oncology. 2020-06-25
9 citations
Propensity Score Matched Comparison of Intensity Modulated Radiation Therapy vs Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Survival Analysis ...
A. Ricco, Alexandra L. Hanlon, Rachelle Lanciano
Frontiers in Oncology. 2017-08-31

Journal Articles

Stereotactic Body Radiotherapy (SBRT) for Liver Metastasis – Clinical Outcomes from the International Multi-Institutional RSSearch® Patient Registry
Rachelle Lanciano, James Kolker, Anuj Peddada, David Perry, Anand Mahadevan, Sanjeev Sharma, Srinath Sundararaman, BioMed Central

Press Mentions

Transitional First-Year Residents from Crozer-Keystone Present Radiation Oncology ResearchMay 16th, 2017